[An example case that chemoradiotherapy was succeeded for unresectable pancreas cancer].
Prognosis of pancreas cancer is extremely poor. For unresectable pancreas cancer, there has not been an effective method of treating. In our institution, the mean survival time was 13 . 6 months for a chemoradiotherapy case that used gemcitabine (GEM), but was 7.3 months for a non-treatment case in locally advanced and metastatic pancreas cancer. This time, we experienced a good case for unresectable pancreas cancer treated with chemoradiotherapy using GEM/S-1 that clearly exhibited a decrease in tumor size by tumor marker.
Dept. of Surgery, Kurume University School of Medicine.
Yusuke
Y
Kawashima
Hiroyuki
H
Horiuchi
Masanori
M
Akashi
Hidefumi
H
Nogita
Yuhei
Y
Kitasato
Gen
G
Akasu
Kazuhiro
K
Mikagi
Ryuichi
R
Kawahara
Hiroto
H
Ishikawa
Toru
T
Hisaka
Hisafumi
H
Kinoshita
Kazuo
K
Shirouzu
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001706:Biopsy; D059248:Chemoradiotherapy; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*; D014057:Tomography, X-Ray Computed; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine